|
Volumn 12, Issue 1, 1992, Pages 19-27
|
Hypertriglyceridemia and regulation of fibrinolytic activity
a a a a a a a |
Author keywords
Endothelial cells; Fibrinolytic activity; HepG2 cells; Hypertriglyceridemia; Plasminogen activator inhibitor 1; Tissue type plasminogen activator; Very low density lipoproteins
|
Indexed keywords
ANTIGEN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
TISSUE PLASMINOGEN ACTIVATOR;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DIET THERAPY;
ENDOTHELIUM CELL;
EUGLOBULIN LYSIS TEST;
FEMALE;
FIBRINOLYSIS;
HEP 2 CELL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPERLIPOPROTEINEMIA TYPE 4;
HYPERTRIGLYCERIDEMIA;
IMMUNOASSAY;
LIPOPROTEIN BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
TRIACYLGLYCEROL BLOOD LEVEL;
UMBILICAL VEIN;
VEIN OCCLUSION;
ADULT;
CARCINOMA, HEPATOCELLULAR;
ENDOTHELIUM, VASCULAR;
FEMALE;
FIBRINOLYSIS;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE IV;
LIPOPROTEINS, VLDL;
LIVER NEOPLASMS;
MALE;
MIDDLE AGE;
PLASMINOGEN INACTIVATORS;
SERUM GLOBULINS;
SUPPORT, NON-U.S. GOV'T;
TISSUE PLASMINOGEN ACTIVATOR;
TRIGLYCERIDES;
TUMOR CELLS, CULTURED;
|
EID: 0026567090
PISSN: 10795642
EISSN: None
Source Type: Journal
DOI: 10.1161/01.ATV.12.1.19 Document Type: Article |
Times cited : (161)
|
References (7)
|